Akzo Nobel N.V (AKZA) | Financial Analysis & Statements
Akzo Nobel N.V. Large-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
2.4B
Gross Profit
936.0M
39.46%
Operating Income
787.0M
33.18%
Net Income
606.0M
25.55%
EPS (Diluted)
€3.48
Balance Sheet Metrics
Total Assets
14.0B
Total Liabilities
9.1B
Shareholders Equity
4.8B
Debt to Equity
1.89
Cash Flow Metrics
Operating Cash Flow
325.0M
Free Cash Flow
362.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Akzo Nobel N.V Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 10.2B | 10.7B | 10.7B | 10.8B | 9.6B |
| Cost of Goods Sold | 6.1B | 6.4B | 6.4B | 6.9B | 5.7B |
| Gross Profit | 4.0B | 4.3B | 4.2B | 3.9B | 3.9B |
| Gross Margin % | 39.9% | 40.5% | 39.7% | 36.2% | 40.7% |
| Operating Expenses | |||||
| Research & Development | 274.0M | 296.0M | 270.0M | 258.0M | 230.0M |
| Selling, General & Administrative | 1.5B | 1.6B | 3.3B | 1.5B | 1.3B |
| Other Operating Expenses | 265.0M | 6.0M | -60.0M | - | - |
| Total Operating Expenses | 2.1B | 1.9B | 3.5B | 1.8B | 1.6B |
| Operating Income | 1.2B | 917.0M | 1.0B | 708.0M | 1.1B |
| Operating Margin % | 11.5% | 8.6% | 9.6% | 6.5% | 11.7% |
| Non-Operating Items | |||||
| Interest Income | 81.0M | 88.0M | 102.0M | 54.0M | 28.0M |
| Interest Expense | 211.0M | 190.0M | 272.0M | 106.0M | 74.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 998.0M | 838.0M | 784.0M | 602.0M | 1.1B |
| Income Tax | 326.0M | 246.0M | 296.0M | 214.0M | 246.0M |
| Effective Tax Rate % | 32.7% | 29.4% | 37.8% | 35.5% | 22.3% |
| Net Income | 671.0M | 592.0M | 483.0M | 378.0M | 865.0M |
| Net Margin % | 6.6% | 5.5% | 4.5% | 3.5% | 9.0% |
| Key Metrics | |||||
| EBITDA | 1.6B | 1.4B | 1.4B | 1.1B | 1.5B |
| EPS (Basic) | €3.71 | €3.17 | €2.59 | €2.01 | €4.48 |
| EPS (Diluted) | €3.69 | €3.16 | €2.59 | €2.01 | €4.46 |
| Basic Shares Outstanding | 170984845 | 170728870 | 170600000 | 174735139 | 184959866 |
| Diluted Shares Outstanding | 170984845 | 170728870 | 170600000 | 174735139 | 184959866 |
Income Statement Trend
Akzo Nobel N.V Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.6B | 1.3B | 1.5B | 1.4B | 1.2B |
| Short-term Investments | 302.0M | 165.0M | 265.0M | 336.0M | 58.0M |
| Accounts Receivable | 2.0B | 2.1B | 2.2B | 2.1B | 2.0B |
| Inventory | 1.5B | 1.7B | 1.6B | 1.8B | 1.6B |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 6.1B | 5.8B | 6.0B | 6.2B | 5.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 999.0M | 1.1B | 1.0B | 1.1B | 1.0B |
| Goodwill | 5.2B | 5.5B | 5.5B | 5.4B | 4.8B |
| Intangible Assets | 2.4B | 2.6B | 2.7B | 2.7B | 2.5B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.8B | 1.9B | - | - | - |
| Total Non-Current Assets | 7.9B | 8.4B | 8.5B | 8.5B | 8.5B |
| Total Assets | 14.0B | 14.2B | 14.6B | 14.7B | 13.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 2.2B | 2.2B | 2.3B | 2.2B | 2.4B |
| Short-term Debt | 1.2B | 1.7B | 2.4B | 2.5B | 1.6B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 27.0M | 38.0M | - | - | - |
| Total Current Liabilities | 4.2B | 4.7B | 5.7B | 5.7B | 4.9B |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.7B | 3.7B | 3.2B | 3.3B | 2.0B |
| Deferred Tax Liabilities | 487.0M | 491.0M | 557.0M | 561.0M | 567.0M |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 4.9B | 4.7B | 4.3B | 4.4B | 3.4B |
| Total Liabilities | 9.1B | 9.4B | 10.0B | 10.2B | 8.2B |
| Equity | |||||
| Common Stock | 86.0M | 85.0M | 85.0M | 87.0M | 91.0M |
| Retained Earnings | 559.0M | - | - | - | 749.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.8B | 4.8B | 4.5B | 4.5B | 5.6B |
| Key Metrics | |||||
| Total Debt | 4.9B | 5.4B | 5.6B | 5.9B | 3.6B |
| Working Capital | 1.9B | 1.1B | 338.0M | 498.0M | 479.0M |
Balance Sheet Composition
Akzo Nobel N.V Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 672.0M | 592.0M | 488.0M | 388.0M | 859.0M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 165.0M | -277.0M | 274.0M | -229.0M | -679.0M |
| Operating Cash Flow | 283.0M | 388.0M | 968.0M | 177.0M | 184.0M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | 816.0M | 3.0M | -18.0M | -552.0M | -51.0M |
| Investment Purchases | -314.0M | -320.0M | -64.0M | -1.4B | -56.0M |
| Investment Sales | 174.0M | 423.0M | 142.0M | 1.1B | 247.0M |
| Investing Cash Flow | 686.0M | 175.0M | 142.0M | -831.0M | 139.0M |
| Financing Activities | |||||
| Share Repurchases | - | 0 | 0 | -669.0M | -1.1B |
| Dividends Paid | -382.0M | -385.0M | -368.0M | -379.0M | -391.0M |
| Debt Issuance | 2.5B | 2.3B | 5.8B | 9.5B | 1.1B |
| Debt Repayment | -3.0B | -2.6B | -6.3B | -7.3B | -590.0M |
| Financing Cash Flow | -981.0M | -684.0M | -827.0M | 1.1B | -974.0M |
| Free Cash Flow | 606.0M | 367.0M | 840.0M | -29.0M | 317.0M |
| Net Change in Cash | -12.0M | -121.0M | 283.0M | 487.0M | -651.0M |
Cash Flow Trend
Akzo Nobel N.V Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
14.47
Forward P/E
12.60
Price to Book
1.97
Price to Sales
0.90
PEG Ratio
0.05
Profitability Ratios
Profit Margin
6.25%
Operating Margin
17.37%
Return on Equity
13.95%
Return on Assets
3.60%
Financial Health
Current Ratio
1.44
Debt to Equity
100.83
Beta
1.16
Per Share Data
EPS (TTM)
€3.70
Book Value per Share
€27.23
Revenue per Share
€59.41
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| AKZA | 9.0B | 14.47 | 1.97 | 13.95% | 6.25% | 100.83 |
| DSM-Firmenich AG | 16.2B | 53.42 | 0.89 | 1.66% | -11.97% | 28.64 |
| IMCD N.V | 5.7B | 26.18 | 2.79 | 10.22% | 4.53% | 87.66 |
| Corbion N.V | 1.1B | 14.56 | 1.43 | 9.87% | 5.90% | 60.14 |
| OCI N.V | 766.7M | 27.05 | 0.84 | -20.70% | 16.92% | 14.45 |
Financial data is updated regularly. All figures are in the company's reporting currency.